Health and Me on MSN5h
Weight-loss Drug Ozempic Can Benefit Patients With Kidney Diseases
In the US, 1 in 7 adults are experiencing some type of chronic kidney disease caused by diabetes. The new approval therefore allows doctor to prescribe Ozempic to lower the risk of kidney failure, ...
Hosted on MSN7h
Lighter but weaker? The hidden costs of Ozempic and weight-loss drugs for endurance athletes
Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...
VegNews9h
Is the Coffee Loophole Diet a Natural Alternative to Diet Drugs?
The coffee loophole diet is the latest weight-loss trend blending coffee and metabolism-boosting ingredients. There are ...
Doctors Explain If Red Light Therapy Really Works for Weight Loss
Some people are using red light therapy to try to lose weight, but doctors say there are a few things to be aware of before ...
From anti-vaccine advocacy to raw milk, many of RFK Jr.’s views fall outside the mainstream
WASHINGTON (AP) — Robert F. Kennedy Jr.’s anti-vaccine advocacy is outside the mainstream. His previous statements on ...
How to Save on Weight Loss Drugs: Navigating Insurance and Discounts
Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.
Josh Gad reveals he had to stop taking weight-loss drug due to side effects: ‘Really bummed out’
The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...
healthday17h
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Ascendis-Novo Weight Loss Deal Highlights Technology Platform, Signals Growth Potential (Rating Upgrade)
TransCon CNP matches BioMarin's Voxzogo for achondroplasia with plans for regulatory filings in 2025, showing potential for ...
Jim Cramer Says Novo Nordisk A/S (NVO) Is ‘Down So Much’
We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...